questionsmedicales.fr
Bactéries
Proteobacteria
Gammaproteobacteria
Vibrionaceae
Vibrionaceae : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vibrionaceae : Questions médicales les plus fréquentes",
"headline": "Vibrionaceae : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vibrionaceae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-17",
"dateModified": "2025-03-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vibrionaceae"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Gammaproteobacteria",
"url": "https://questionsmedicales.fr/mesh/D020563",
"about": {
"@type": "MedicalCondition",
"name": "Gammaproteobacteria",
"code": {
"@type": "MedicalCode",
"code": "D020563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio",
"alternateName": "Aliivibrio",
"url": "https://questionsmedicales.fr/mesh/D059706",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio",
"code": {
"@type": "MedicalCode",
"code": "D059706",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aliivibrio fischeri",
"alternateName": "Aliivibrio fischeri",
"url": "https://questionsmedicales.fr/mesh/D048908",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio fischeri",
"code": {
"@type": "MedicalCode",
"code": "D048908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.860"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Aliivibrio salmonicida",
"alternateName": "Aliivibrio salmonicida",
"url": "https://questionsmedicales.fr/mesh/D044165",
"about": {
"@type": "MedicalCondition",
"name": "Aliivibrio salmonicida",
"code": {
"@type": "MedicalCode",
"code": "D044165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.050.930"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Listonella",
"alternateName": "Listonella",
"url": "https://questionsmedicales.fr/mesh/D053526",
"about": {
"@type": "MedicalCondition",
"name": "Listonella",
"code": {
"@type": "MedicalCode",
"code": "D053526",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Photobacterium",
"alternateName": "Photobacterium",
"url": "https://questionsmedicales.fr/mesh/D010776",
"about": {
"@type": "MedicalCondition",
"name": "Photobacterium",
"code": {
"@type": "MedicalCode",
"code": "D010776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio",
"alternateName": "Vibrio",
"url": "https://questionsmedicales.fr/mesh/D014733",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio",
"code": {
"@type": "MedicalCode",
"code": "D014733",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio alginolyticus",
"alternateName": "Vibrio alginolyticus",
"url": "https://questionsmedicales.fr/mesh/D044149",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio alginolyticus",
"code": {
"@type": "MedicalCode",
"code": "D044149",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae",
"alternateName": "Vibrio cholerae",
"url": "https://questionsmedicales.fr/mesh/D014734",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae",
"code": {
"@type": "MedicalCode",
"code": "D014734",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae non-O1",
"alternateName": "Vibrio cholerae non-O1",
"url": "https://questionsmedicales.fr/mesh/D044163",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae non-O1",
"code": {
"@type": "MedicalCode",
"code": "D044163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O1",
"alternateName": "Vibrio cholerae O1",
"url": "https://questionsmedicales.fr/mesh/D041241",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O1",
"code": {
"@type": "MedicalCode",
"code": "D041241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.151"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio cholerae O139",
"alternateName": "Vibrio cholerae O139",
"url": "https://questionsmedicales.fr/mesh/D041242",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio cholerae O139",
"code": {
"@type": "MedicalCode",
"code": "D041242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.100.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio mimicus",
"alternateName": "Vibrio mimicus",
"url": "https://questionsmedicales.fr/mesh/D044164",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio mimicus",
"code": {
"@type": "MedicalCode",
"code": "D044164",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio parahaemolyticus",
"alternateName": "Vibrio parahaemolyticus",
"url": "https://questionsmedicales.fr/mesh/D014736",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio parahaemolyticus",
"code": {
"@type": "MedicalCode",
"code": "D014736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.590"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vibrio vulnificus",
"alternateName": "Vibrio vulnificus",
"url": "https://questionsmedicales.fr/mesh/D041261",
"about": {
"@type": "MedicalCondition",
"name": "Vibrio vulnificus",
"code": {
"@type": "MedicalCode",
"code": "D041261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B03.660.250.830.830.900"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vibrionaceae",
"alternateName": "Vibrionaceae",
"code": {
"@type": "MedicalCode",
"code": "D014737",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Chunqi Jiang",
"url": "https://questionsmedicales.fr/author/Chunqi%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Sayaka Mino",
"url": "https://questionsmedicales.fr/author/Sayaka%20Mino",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan."
}
},
{
"@type": "Person",
"name": "Jesús L Romalde",
"url": "https://questionsmedicales.fr/author/Jes%C3%BAs%20L%20Romalde",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Microbiología y Parasitología, CRETUS & CIBUS-Facultad de Biología, Universidade de Santiago de Compostela, Campus Vida, Santiago de Compostela, España."
}
},
{
"@type": "Person",
"name": "Tomoo Sawabe",
"url": "https://questionsmedicales.fr/author/Tomoo%20Sawabe",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Microbiology, Faculty of Fisheries Sciences, Hokkaido University, Hakodate, Japan. sawabe@fish.hokudai.ac.jp."
}
},
{
"@type": "Person",
"name": "William Soto",
"url": "https://questionsmedicales.fr/author/William%20Soto",
"affiliation": {
"@type": "Organization",
"name": "Integrated Science Center Rm 3035, Department of Biology, College of William & Mary, 540 Landrum Dr., Williamsburg, VA 23185, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39273131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36163292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.disamonth.2022.101468"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2022.09.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35931315",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.autrev.2022.103167"
}
},
{
"@type": "ScholarlyArticle",
"name": "Scleroderma autoantibodies in guiding monitoring and treatment decisions.",
"datePublished": "2022-08-29",
"url": "https://questionsmedicales.fr/article/36082759",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/BOR.0000000000000904"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Bactéries",
"item": "https://questionsmedicales.fr/mesh/D001419"
},
{
"@type": "ListItem",
"position": 3,
"name": "Proteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020560"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gammaproteobacteria",
"item": "https://questionsmedicales.fr/mesh/D020563"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vibrionaceae",
"item": "https://questionsmedicales.fr/mesh/D014737"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vibrionaceae - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vibrionaceae",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vibrionaceae",
"description": "Comment diagnostiquer une infection par Vibrionaceae ?\nQuels tests sont utilisés pour identifier Vibrio cholerae ?\nLes tests sérologiques sont-ils utiles pour Vibrionaceae ?\nQuels symptômes indiquent une infection vibrionique ?\nComment différencier Vibrionaceae d'autres bactéries ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vibrionaceae",
"description": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?\nLes infections vibrioniques causent-elles des vomissements ?\nY a-t-il des symptômes graves associés aux Vibrionaceae ?\nLes symptômes apparaissent-ils rapidement après infection ?\nLes infections vibrioniques peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vibrionaceae",
"description": "Comment prévenir les infections par Vibrionaceae ?\nLes vaccins existent-ils contre Vibrionaceae ?\nQuelles mesures de sécurité alimentaire sont recommandées ?\nLes voyageurs doivent-ils prendre des précautions ?\nL'hygiène des mains est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vibrionaceae",
"description": "Quel est le traitement principal pour les infections par Vibrionaceae ?\nLes antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?\nComment prévenir la déshydratation dans les infections vibrioniques ?\nLes traitements symptomatiques sont-ils efficaces ?\nY a-t-il des traitements spécifiques pour le choléra ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vibrionaceae",
"description": "Quelles complications peuvent survenir avec Vibrionaceae ?\nLe choléra peut-il entraîner des complications graves ?\nLes infections vibrioniques peuvent-elles être mortelles ?\nComment les complications sont-elles gérées ?\nLes personnes âgées sont-elles plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vibrionaceae",
"description": "Quels sont les principaux facteurs de risque d'infection ?\nLes personnes immunodéprimées sont-elles à risque ?\nLe climat influence-t-il le risque d'infection ?\nLes enfants sont-ils plus vulnérables ?\nLes voyages dans certaines régions augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D014737?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par Vibrionaceae ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par culture bactérienne à partir d'échantillons de selles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour identifier Vibrio cholerae ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des méthodes moléculaires comme la PCR sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques sont-ils utiles pour Vibrionaceae ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils ne sont généralement pas utilisés pour le diagnostic des infections vibrioniques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection vibrionique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la diarrhée, les vomissements et la déshydratation peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment différencier Vibrionaceae d'autres bactéries ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse des caractéristiques morphologiques et des tests biochimiques aide à la différenciation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une infection par Vibrionaceae ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, crampes abdominales et fièvre."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques causent-elles des vomissements ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vomissements sont fréquents, surtout dans les cas de choléra."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes graves associés aux Vibrionaceae ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves incluent la déshydratation sévère et le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement après infection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent être asymptomatiques, surtout chez les porteurs sains."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par Vibrionaceae ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène, la cuisson des aliments et l'eau potable."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre Vibrionaceae ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un vaccin contre le choléra est disponible, mais pas pour toutes les espèces de Vibrionaceae."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité alimentaire sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de bien cuire les fruits de mer et de ne pas consommer d'eau non traitée."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils prendre des précautions ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des zones à risque doivent être prudents avec l'eau et la nourriture."
}
},
{
"@type": "Question",
"name": "L'hygiène des mains est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se laver les mains régulièrement est crucial pour prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections par Vibrionaceae ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation orale ou intraveineuse est le traitement principal, surtout pour le choléra."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils nécessaires pour traiter Vibrionaceae ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antibiotiques peuvent être prescrits dans les cas graves, mais ne sont pas toujours nécessaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la déshydratation dans les infections vibrioniques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration rapide de solutions de réhydratation est essentielle pour prévenir la déshydratation."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements symptomatiques comme les antiémétiques peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour le choléra ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antibiotiques spécifiques et des solutions de réhydratation sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec Vibrionaceae ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la déshydratation sévère, le choc et l'insuffisance rénale."
}
},
{
"@type": "Question",
"name": "Le choléra peut-il entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le choléra peut entraîner des complications graves comme le choc hypovolémique."
}
},
{
"@type": "Question",
"name": "Les infections vibrioniques peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement approprié, les infections peuvent être mortelles, surtout chez les vulnérables."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par une réhydratation rapide et un traitement médical approprié."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'eau contaminée."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque accru d'infections graves."
}
},
{
"@type": "Question",
"name": "Le climat influence-t-il le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections par Vibrionaceae sont plus fréquentes dans les climats chauds et humides."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux infections et à leurs complications."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines régions augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des régions à risque augmente la probabilité d'infection par Vibrionaceae."
}
}
]
}
]
}
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
Pulmonary Arterial Hypertension (PAH) is a clinical syndrome consisting of physiologic/hemodynamic criteria that are a consequence of several etiologies. Systemic Sclerosis (SSc), one of the most comm...
Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort....
Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?...
We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II...
In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529...
The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...
Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with...
Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi...
Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0...
Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc...
We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul...
The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv...
SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...
Systemic sclerosis (SSc) represents extremely rare disease with majority of data coming from adults. Studies comparing juvenile- (jSSc) and adult-onset (aSSc) patients are limited. We aimed to compare...
A retrospective study among pediatric and adult Scl patients has been performed. Demographic characteristics, clinical features, autoantibody profiles, and treatment data were retrieved from the datab...
A total of 158 adults and 58 juvenile Scl patients were identified. The mean age at the disease onset was 37±14.7 vs. 8.8 ± 4.1 years, mean age at diagnosis 42±15.2 vs. 10.4 ± 3.8 years and mean follo...
Juvenile and adult-onset Scl represent rarely seen conditions with different clinical phenotypes. Pediatric patients with LS are more commonly seen by pediatric rheumatologists, in contrary to adults....
Systemic sclerosis (SSc), also known as scleroderma, is a chronic autoimmune connective tissue disease and is associated with a significant economic burden resulting from health care utilization costs...